We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 230,111 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/9/2018 09:17 | Costax you looney this is going down fast. | ken chung | |
20/9/2018 08:11 | Nestle to spin off it's care business | hampton58 | |
20/9/2018 00:48 | Raywhack, no hope for you, with each stroke of a key you look a bigger fool. | slartybartfaster | |
20/9/2018 00:15 | The only thing false on this thread is you rayrat get over tw it will damage you even more than it has already ukog down from 8p to 2p massive loss bpc from down 76% since August 23rd you really are a bitter fool | manc10 | |
19/9/2018 23:34 | It’ll be a false bounce if it is, slartyfartfaster! A cream for curing eczema and psoriasis and no proper phase 1/2/3 trials? Not a hope. The NHS and medical profession, would be jumping all over it if it was able to cure the above. | rayrac | |
19/9/2018 18:20 | All i can say is thank f&ck our northern fella has his fingers on the pulse. I don't mind saying i was getting worried for SBTX. We should get a bounce from both this week and next. | slartybartfaster | |
19/9/2018 17:31 | We should start slowly recovering...and heading into the right direction! Commercialisation is still feasible in 2018 based on the data we'll have by the end of the year. Our intention is to licence the technology rather than commercialise our own products. | costax1654x | |
19/9/2018 15:53 | Hopefully, we will see a bounce from here as the fall is rather overdone IMHO. | rafboy | |
19/9/2018 11:03 | Roll Not a good time to be out of this one, news could still come via big commercial partners.A big company is out there now testing this cream, and if it does what Cath says then bingo.And it's no small trial, it's huge for this company. | anderson3 | |
19/9/2018 08:45 | Unsurprisingly trial commencement triggers some selling. Sp going nowhere for a month or so. | rollthedice | |
19/9/2018 08:44 | Oh? And what makes you think that, rafboy. It’s still probably grossly overvalued...fail this so called trial and it’s reason for existence disappears. But as its a in-house trial, no phase 1/2/3, they’ll probably!!! | rayrac | |
19/9/2018 08:32 | The fall is overdone though. | rafboy | |
19/9/2018 08:20 | Oh dear, it’s run by amateurs who haven’t a clue, other than to spin some story that they have a cure for most skin deceases. Believe that and you’ll believe anything! | rayrac | |
19/9/2018 08:16 | Instead of repeating here why not simply email Cath and ask | onedayrodders | |
19/9/2018 07:44 | The placebo effect is much less in skin because there is no subjectivity, you can see the resultunlike other organ systems. That is why most Pharmas POC studies with immunosuppressives are now in psoriasis because there is no problem with placebo effects. | nobbygnome | |
19/9/2018 07:39 | Still not making it a double blind trial. Or even a single blind trial. Why not? Doesn't cost any more. Or make it any more complex. But would have given the trial a lot more credibility. | someuwin | |
19/9/2018 07:26 | So the format of the trails as changed completely since the two recent presentationts now if that is the case it’s a worry if not as I suspect why was this not put across at the presentation investors will be baffled by the completely different format never any mention of three different trails and the important one starting in November now .It's not a negative in anyway but just misleading from what was stated at the meetings which is poor from investor trust perspective | best1467 | |
19/9/2018 07:18 | So tests have started. Much more comprehensive than I thought. Should see some initial results next month. | rafboy | |
19/9/2018 00:34 | Lovin the action 50% bagged twice. Lucky I guess but both times thought share went up too quick. I used bollinder bands and they were very stretched. I've lost money in the past but learnt if you want to make money you must make yourself available ie take the trade and realise when to sell. Tough game for some! SBTX chart looks healthy and there is interest so until that changes I will carry on buying and selling. I think next attack on 30p will break. Good luck to those who make themselves available. | danatkins | |
18/9/2018 22:11 | Slarty, I thought the trials started last week. | rafboy | |
18/9/2018 20:00 | try the oil sector ukog down massive losses bpc down 80% since you advised the inexperienced investor to buy you are not regulated so do not advise people how to lose everything rayrat | manc10 | |
18/9/2018 17:21 | I quoted a figure posted on here, but even 120 is a pathetic figure, compared to a genuine phase 1/2/3 trial where they go into 1000s! Hyped up fraud? The oil is either there or it isn’t, I can live with that. But to have directors making unsubstantiated claims for untested products, is close to being criminal imo. | rayrac | |
18/9/2018 17:13 | Try the oil sector 2350220. But beware, there are good and bad, bad like we have here and at Opti. There are people here who are out to deceive! | rayrac |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions